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The 2015–2017 Zika Virus outbreak caused a high increase in patients with 
Guillain-Barré syndrome (GBS), a post infectious autoimmune disease of the 
peripheral nerves. The severity of GBS can range from mild impairment with fast 
recovery to complete paralysis including severe respiratory or autonomic failure. 
Recovery may take months and even years and may be incomplete despite disease 
modifying treatment with IVIG or plasma exchange. Therefore, optimal supportive 
care and effective rehabilitation remain crucial. Multidisciplinary rehabilitation is 
recommended but may be challenging in the acute phase because of limited patient 
participation due to profound muscle weakness and severe pain. Inactive dener-
vated muscles will inevitably undergo rapid degeneration resulting in wasting, 
weakness, and contractures as major long-term complications in severely affected 
patients. In this chapter, the current evidence of rehabilitation on the short- and 
long-term motor function in GBS is reviewed, including newly obtained experi-
ences with neuromuscular electrical stimulation (NMES). Rehabilitation remains 
an area lacking well designed and controlled clinical studies and thus a clear lack of 
evidence-based guidelines.
Keywords: Guillain Barré syndrome, prognosis, chronic disability, rehabilitation, 
exercise, neuromuscular electrical stimulation
1. Introduction
Guillain Barré Syndrome (GBS) is an acute inflammatory disease affecting 
peripheral nerves and nerve roots [1, 2]. Most commonly, GBS is preceded by 
an infection a few weeks prior to neuropathic symptoms [3]. Thus, incidence of 
GBS can increase during outbreaks of infectious diseases. This was most recently 
observed during the 2015 to 2017 Zika Virus epidemic in the French Polynesia and 
Latin America with a highly increased incidence of GBS in several countries [4–9]. 
GBS typically presents with muscle weakness and sensory symptoms combined 
with loss of tendon reflexes. Symptoms initially present in the lower extremities 
progressing to the upper extremities and the respiratory and cranial muscles [10]. 
The progressive phase usually last for days to weeks with most patients reaching 
nadir within four weeks of symptom debut followed by a plateau phase and a slow 
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recovery. Beside the typical presentation of sensory and motor neuropathy, patients 
may have clinical variants like the triad of ophthalmoplegia, ataxia and areflexia 
known as the Miller Fischer Syndrome, pure motor, paraparetic or pharyngea-
cervical-brachial variant [11], and in association with Zika Virus infection a case of 
GBS with ocular flutter, ataxia, tetraparesis and areflexia has been reported [12]. 
Furthermore, neuropathy can be classified as demyelinating or axonal according to 
the electrophysiological examination [13].
The prognosis of GBS is very heterogeneous. Some patients are mildly affected 
with a fast recovery and no disabilities irrespective of receiving any treatment. 
Between 20 and 30% of patients develop complete paralysis, severe respiratory or 
autonomic failure and receive treatment in the intensive care unit (ICU) for months 
[14]. In a group of prolonged mechanically ventilated patients, 31% were able to 
walk after one year and 58% after maximum time of follow up [15]. The sudden 
increase of patients with Zika Virus-related GBS was a challenge for health care 
systems in low income countries such as Brazil with limited resources for diagnos-
tics, treatment, ICU capacity as well as rehabilitation facilities [1, 2]. Despite the 
lack of evidence, multidisciplinary supportive care and rehabilitation are important 
in GBS. In the acute phase, consensus- based recommendations include (1) moni-
toring of respiratory and autonomic function in a setting with available artificial 
ventilation and neuro-intensive care, (2) prophylactic antithrombotic treatment for 
deep vein thrombosis, (3) pain management, (4) management of nutrition as well 
as bladder and bowel dysfunction and (5) physiotherapy to prevent muscle short-
ening and joint contractures [16]. All of these interventions should be followed by 
a rehabilitation and exercise program to regain physical abilities as fast as possible. 
Recovery can take months and even years and end up with significant chronic 
disabilities despite immunomodulatory treatment. As shown in the largest prospec-
tive cohort of patients with GBS studied to date, a large proportion of patients 
had long-term motor dysfunction with 17% of patients from Europe and America 
were unable to walk unaided after 12 months [17], emphasizing the importance 
of identifying more effective neuromuscular rehabilitation. Motor dysfunctions 
such as weakness, wasting and contractures are major long-term complications 
in severely affected patients. In this review, we present an overview of existing 
evidence of treatment to prevent muscle weakness and disabilities after GBS with 
special emphasis on the effect of neuromuscular rehabilitation in the acute and 
chronic phases of the disease.
2. Treatment and rehabilitation in GBS
Pharmacological treatment. In several large randomized controlled clinical 
trials, treatment with plasma exchange (PE) or intravenous immunoglobulin (IVIG) 
initiated in the acute phase of GBS have proven effective. Compared to placebo, treat-
ment with PE or IVIG result in reduced need for respiratory support and an increased 
chance to regain mobility and muscle strength after 1 month and 12 months [18, 19]. 
Despite immunomodulatory treatment, a group of patients with GBS still have a very 
poor prognosis. In a combined cohort study of 526 patients and a cross sectional study 
including 63 ventilated patients [15], 6% of patients with GBS required mechani-
cal ventilation for more than two months. The prolonged mechanically ventilated 
patients had a median (range) length of stay at the ICU of 101 (97–126) days and at 
hospital of 129 (104–162) days, followed by 252 (177–403) days of clinical rehabili-
tation and 198 (183–502) days of outpatient rehabilitation. At 11 years follow-up, 
only 58% had regained ambulation and the median time to regain ambulation was 
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548 (270–730) days. This emphasizes the need for more effective treatment in GBS. 
Recently, small clinical studies have indicated that monoclonal antibodies against 
complement proteins given in the early phase of the disease could have some benefit 
in GBS; however, larger studies are needed to confirm this [20, 21]. It is important 
to underline that there are currently no evidence-based pharmacological treatments 
available to prevent muscle atrophy or muscle weakness in GBS [22].
Multidisciplinary rehabilitation. Most patients with moderate to severe GBS 
are offered multidisciplinary rehabilitation, which means two or more coordi-
nated interventions under medical supervision by a neurologist or rehabilitation 
physician. Multidisciplinary rehabilitation aims at regaining autonomy with the 
ability to perform all activities of daily living. This may include physiotherapy 
or occupational therapy and exercise programs, but also nursing, dietary advice, 
psychotherapy, speech therapy, and social rehabilitation depending on the needs 
of the individual patient. The individualized approach to multidisciplinary 
rehabilitation as well as a considerably variability in facilities between countries 
and hospitals compromise the possibility to design research trials to assess the 
efficacy of a multidisciplinary rehabilitation intervention. In a systematic review 
of rehabilitation interventions in patients with GBS [23], only five original studies 
could be identified evaluating the effectiveness of multidisciplinary rehabilitation. 
These studies include only one good quality randomized controlled study compar-
ing high and low intensity rehabilitation in patients with remaining disability 
more than one year after GBS [24]. In this study, 79 adult patients were included 
1–12 years after the GBS diagnosis and randomized to receive either individualized 
outpatient-based high-intensive rehabilitation (intervention, n = 40) or a lower 
intensity home-based program (control, n = 39). The intervention comprised three 
one-hour individualized sessions weekly for 12 weeks. Sessions included physical 
and occupational therapy for strengthening, endurance and gait training as well 
as specific rehabilitation tasks to improve everyday life activities as well as com-
munity and work functions. The control group completed a 30-minute maintenance 
training program twice weekly and was also allowed to perform other rehabilitation 
activities if needed. Outcome was assessed one year after the intervention and 
included measurements of activity level, participation, and perceived impact of 
disease-related problems. Based on the total and the motor scales of the Functional 
Independence Measure (FIM) in an intention to treat analysis, there was a small 
but statistically significant improvement in the high intensity rehabilitation group 
compared to the controls. Furthermore, 80% of the patients complying with 
the high intensity protocol had a clinically meaningful improvement in the FIM 
motor score (at least 3 points) compared with only 8% of controls. Adverse effects 
were not reported; however, only 22 (55%) of the 40 patients assigned to high 
intensity rehabilitation completed the study due to loss to follow up or inability or 
unwillingness to comply with the protocol. This low number of follow-up reduces 
the applicability and external validity of the study suggesting that applicability of 
the intervention is challenging. Other original studies have included: (1) one case 
control study (n = 34) of inpatient rehabilitation with a control group of healthy 
subjects [25], (2) one prospective case series (n = 35) of inpatient rehabilitation 
followed by a home-based training program [26], and (3) two retrospective case 
series (n = 39 and 24) of inpatient rehabilitation [27, 28]. In these studies, patients 
with GBS improved during multidisciplinary rehabilitation but the studies were not 
designed to distinguish between spontaneous recovery and the effect of the reha-
bilitation intervention.
Despite several limitations, the authors of the review concluded that there is 
good evidence (Grade level II) to support ambulatory, outpatient multidisciplinary 
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rehabilitation to obtain long-term improvements in levels of activity and partici-
pation in patients with GBS in the later stages of recovery. Further, the authors 
concluded that there is satisfactory (Grade level III) evidence to support (1) 
inpatient rehabilitation followed by outpatient rehabilitation thereby inducing 
functional recovery and (2) physical therapy and exercise to reduce joint contrac-
tures and muscle weakness. In another more recent case series of 51 patients with 
GBS, motor recovery following the acute pharmacological treatment response was 
assessed during the acute inpatient care as well as after outpatient and homebased 
rehabilitation [29]. A description of the intervention was not provided, but it 
included physical therapy for 61 ± 58 (mean ± SD) days for inpatients, 96 ± 70 days 
for outpatients, and 75 ± 15 days during home rehabilitation. Again, the natural 
history with spontaneous improvement after GBS and the lack of a control 
group impairs the possibility to draw any final conclusions based on this study 
regarding the effectiveness of rehabilitation. However, it was shown that muscle 
strength measured with a MRC sum score [30] and ambulation assessed with 
the GBS disability score [31] continue to improve beyond the first six months of 
rehabilitation.
Exercise. In a systematic review, Simatos and colleagues evaluated the 
available literature on exercise as an intervention in the rehabilitation of adult 
patients with GBS [32]. Studies between 1951 and 2016 were identified in PubMed 
searches and the quality of the studies was assessed and classified according to a 
modified version of the Centre for Evidence-Based Medicine level of evidence. 
Seven studies with exercise as the main intervention were identified, includ-
ing four uncontrolled single cases with a low evidence level, one trial including 
multidisciplinary rehabilitation (reviewed in the previous section), [24], and 
two Dutch studies of a case series in an open label standardized exercise protocol 
(evidence level 5) [33, 34]. In the Dutch study, 16 patients were included between 
six months and 15 years after their GBS diagnosis as well as four patients with 
stable chronic inflammatory demyelinating polyradiculoneuropathy. All patients 
were ambulatory and reported fatigue as a major complaint. The exercise inter-
vention consisted of three 45-minute bicycling sessions every week for 12 weeks. 
During the 12-week period, training intensity was gradually increased. The target 
heart rate increasing from 65% to a maximum of 90% of maximal heart rate and 
an increasing workload was applied on the bicycle home trainer. The intervention 
resulted in lower fatigue levels, increased isokinetic muscle strength and a higher 
peak oxygen uptake. Further, patients improved on a handicap scale and on the 
physical components score of the SF36 Quality of Life scale. Two patients did not 
complete the study for non-study related reasons, and 25% reported mild and 
transient muscle cramps, paresthesia, or pain. Overall, exercise as an intervention 
in patients with late disabilities and fatigue in GBS is feasible and may benefit 
some patients.
Neuromuscular electrical stimulation (NMES). In the acute phase of severe 
GBS, rehabilitation exercise is challenged by limited patient participation due 
to severe weakness or even paralysis. For practical reasons, exercise may also 
be challenged if patients are in the ICU, intubated and on ventilator support. 
Inactive and denervated muscles will indisputably and fast degenerate and muscle 
atrophy will develop [35, 36]. NMES is a method to induce muscle contractions 
without patient participation. This may be an alternative therapeutic approach 
in the acute phase of GBS, which can minimize inactivation and denervation 
wasting until patients have recovered to a level where a multidisciplinary reha-
bilitation effort can be initiated [37, 38]. In a small proof of concept study this 
has proven feasible with satisfactory safety. There was also a trend for an effect of 
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NMES on muscle wasting as an add on to established standard of care in the acute 
and subacute phases of GBS [39]. Seventeen patients with moderate to severe GBS 
were randomized to receive an hour of NMES on weekdays on the right or left 
quadriceps femoral muscle with the non-stimulated muscle serving as control. 
Stimulation was initiated within two weeks after the first sign of weakness and 
was continued through the acute hospital admission and the following inpatient 
rehabilitation. The median (range) time of participation was 27 days (10–95) 
and included 17 (4–53) stimulation sessions. During the study, each patient had 
a mean loss of lean body mass (muscle) of 3.4 kg, establishing that patients with 
GBS will experience substantial muscle wasting. NMES was found to be safe and 
feasible as an add on to standard supportive therapy and rehabilitation in the 
acute and subacute phases of GBS. There was a trend towards a preventive effect 
of NMES on muscle atrophy, but the study was not designed to explore effect on 
patient disability.
Virtual Motor Rehabilitation System. Virtual Motor Rehabilitation (VMR) is 
a new technology combining novel rehabilitation software with low cost commer-
cially available devices such as the Nintendo® Wii platform. To be effective, mul-
tidisciplinary rehabilitation in GBS is very time demanding including several daily 
sessions for as long as 6, 12 and 18 months [40]. Often the rehabilitation offered is 
limited due to lack of time and resources, and patients may find training tedious 
and monotonous, resulting in lack of compliance. Therefore, VMR could be an 
attractive supplement to the established rehabilitation regimen. The method is still 
under development and so far only one study has been published, describing VMR 
applied four and five months after admission in two patients with severe GBS as an 
add on to the conventional multidisciplinary rehabilitation [41]. In this study, the 
Nintendo® Wii Balance Board and a virtual environmental tool were applied in 20 
rehabilitation sessions consisting of 30 minutes of traditional therapy and 30 min-
utes of VMR. Compliance was good and patients’ status improved. VMR could be 
developed further to include more aspects of the rehabilitation process in the future.
Safety. In anecdotal case reports and experimental animal studies it has been 
indicated that over-exercising during rehabilitation after GBS may damage motor 
units and cause paradoxical weakening, which has led to hesitation concerning the 
recommendation to do intensive and strenuous exercise [16]. The clinical data to 
support this concern are negligible and overall, it is reasonable to believe that the 
benefit of exercising weakened muscles after GBS excess the risk of harm. However, 
systematic registration of safety and complications should always be included in 
future studies.
3. Conclusions
Neuromuscular rehabilitation after GBS is important for the functional out-
come of each individual patient. Studied rehabilitation interventions in the acute, 
subacute/intermediate, and chronic/long-term phase are summarized in Figure 1. 
However, the quality of the present evidence of rehabilitation efficacy is low, reha-
bilitation is both complex, time consuming and expensive, and there is currently no 
standardized care for patients with neuromuscular disabilities after GBS. Therefore, 
the rehabilitation effort may lack necessary resources and expertise. Because the 
monophasic course and spontaneous recovery in GBS challenge the interpretation 
of non-controlled studies, future large controlled studies and standardized sensitive 
efficacy outcome measures are needed to improve the interpretation of neuromus-
cular rehabilitation trials in GBS.
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4. Policy and procedures
Neuromuscular Electrical Stimulation Protocol.
Stimulation of the quadriceps muscle was performed using a STIWELL med4 
stimulation unit, https://www.ottobock.co.th/neurorehabilitation/solutions/solu-
tions-with-functional-electrical-stimulation/stiwell-med-4/(Otto Bock, Konigsee, 
Germany) and two large stimulation pads (6 × 8 cm). The intensity of electrical 
stimulation was titrated individually at entry and weekly during the study to the 
point of maximal contraction or the highest tolerable intensity. During the first 
session of stimulation, the skin under the pads was inspected every five minutes for 
redness or other signs of tissue damage. Trained physical therapists attached the 
equipment and titrated the stimulation intensity, but after being attached to the 
patient the individualized stimulation protocol ran automatically.
Direct muscle fiber stimulation (MFS). With MFS, contraction is induced 
directly through the muscle fiber membrane independent of the neuromuscular 
junction, which means that complete distally denervated muscle fibers can be acti-
vated. The disadvantage is that higher intensity stimulation, especially in atrophic 
muscle, is needed which may cause discomfort and skin irritation. MFS was applied 
by placing two pads over the proximal and distal part of the muscle (Figure 2) with 
triangular dual-phase stimulation pulses. The initiation protocol was 1 Hz frequency, 
Figure 1. 
Neuromuscular rehabilitation in three phases of Guillain Barré syndrome. Rehabilitation focus and studied 
interventions in three phases of Guillain Barré syndrome, the acute, subacute/intermediate, and chronic/
long-term phase. Level of evidence is indicated using the following grade system: Level 1, meta-analysis of 
multiple well designed randomized controlled trials; level 2, at least one randomized controlled trial; level 3–5, 
non-randomized controlled trials, descriptive studies or case series.
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250 ms pulse width, and 3/6 on/off ratio. The lowest pulse width with maximal 
contraction was chosen and frequency was increased to the highest tolerated level.
Neuromuscular electrical stimulation (NMES). With NMES the muscle is 
activated through the muscle spindle and neuromuscular endplate. As a result, the 
contraction is more physiological and less electrical stimulation is needed. NMES 
was applied by one pad placed on the middle of the muscle bulk, where the neuro-
muscular transmission is located with rectangular dual-phase stimulation pulses. 
The protocol included four phases of 5, 15, 15, and 5 minutes, with frequencies of 
10, 40, 60, 3 Hz, with a pulse width of 0.3 ms. Intensity could be adjusted from 0 to 
100 mA and was increased to the highest tolerated level.
The intention was to stimulate patients five to seven days a week including 
20 minutes of MFS followed by 40 minutes of NMES. Also, the NMES was applied 
to patients where no visible contraction could be observed.
Figure 2. 
Electrical muscle stimulation. A healthy control subject with electrodes in place for direct muscle fiber 
stimulation of the left quadriceps femoris muscle by the STIWELL med4 stimulation unit.
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5. Mini-dictionary of terms
Neuromuscular Electrical Stimulation: A method to induce muscle contrac-
tion by applying an electrical impulse to the neuromuscular endplate by an elec-
tronic device.
Multidisciplinary rehabilitation: Two or more coordinated interventions for 
disabled patients to regain autonomy and functions of daily living. Usually, mul-
tidisciplinary rehabilitation is performed by physical therapists and occupational 
therapists but may include other professions.
Motor dysfunction: Several methods are used to describe motor dysfunction in 
GBS. Muscle weakness is a main feature of GBS, which develops quickly in the acute 
phase. Weakness can be assessed manually with the MRC score on a scale from 0 to 
5. (0, paralysis with no visible contraction; 1, visible contraction but no limb move-
ment; 2, limb movement only with gravity eliminated; 3, active movement against 
gravity; 4, active movement against gravity and resistance but reduced strength; 5, 
normal strength). Weakness may be quantified on a linear scale using a dynamom-
eter [42]. In addition to weakness, chronic muscle dysfunction can result in muscle 
wasting, and muscle and joint contractures and shortening, which is very disabling.
Impairment and disability: Impairment is the direct damage caused by the dis-
ease, for example weakness of leg muscles (as described above) or loss of sensation, 
while disability is the loss of the function caused by the impairment, for example 
loss of ambulation. Often, the GBS disability score is used to describe the severity 
of the disease concerning the level of disability. (0, healthy; 1, minor symptoms 
and capable of running; 2, able to walk 10 m without assistance but unable to run; 
3, able to walk 10 m across an open space with help; 4 bedridden or chair bound; 4, 
requiring assisted ventilation for at least part of the day; 6, death).
6. Key facts of neuromuscular rehabilitation in GBS
Neuromuscular rehabilitation in Guillain Barré Syndrome can include
• Physical therapy to prevent muscle and joint shortening and contractures.
• Multidisciplinary rehabilitation with two or more coordinated interventions 
for disabled patients to regain autonomy and functions of daily living.
• Exercise and training to improve or maintain physical functioning.
• Neuromuscular electrical stimulation to prevent muscle wasting.
The prognosis of Guillain Barré Syndrome
• Guillain Barré Syndrome is a heterogenous disorder with a monophasic course.
• Clinical severity ranges from mild impairment to complete paralysis combined 
with respiratory and autonomic failure.
• In 20 to 30% of patients, mechanical ventilation is required at nadir of GBS.
• The most severely affected patients have a long recovery phase and a poor 
prognosis.
• More than half of all mechanically ventilated patients are unable to walk unas-
sisted at one year follow up.
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7. Summary points of neuromuscular rehabilitation in GBS
• Most commonly, GBS is preceded by an infection, therefore, the incidence 
of GBS can increase during outbreaks of infectious diseases, which was most 
recently observed during the Zika Virus outbreak in the French Polynesia 
and Latin America with a high increase in the incidence of GBS in several 
countries.
• Despite optimal evidence-based treatment with immunoglobulin and plasma 
exchange, a large proportion of patients with GBS will have substantial 
neuromuscular disabilities more than one year after disease onset. Among 
patients receiving mechanical ventilation, more than half will be able to walk 
unassisted.
• In the acute phase of GBS, physical therapy is important to prevent muscle 
shortening and joint contractures.
• Patients may still improve their physical function several years after onset  
of GBS.
• There is evidence to support high intensity multidisciplinary rehabilitation 
and exercise which improves level of activity and participation in the late and 
chronic stages of GBS.
• New approaches like Neuromuscular Electrical Stimulation and Virtual Motor 
Rehabilitation seem to be feasible methods in the acute and late stage recovery 
of GBS, but efficacy needs to be explored in future studies.
Abbreviations
FIM functional independence measure
GBS Guillain Barré syndrome
ICU intensive care unit
IVIG intravenous immunoglobulin
MFS muscle fiber stimulation
NMES neuromuscular electrical stimulation
PE plasma exchange
VMR virtual motor rehabilitation
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